These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19053749)

  • 1. Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells.
    Campbell CT; Aich U; Weier CA; Wang JJ; Choi SS; Wen MM; Maisel K; Sampathkumar SG; Yarema KJ
    J Med Chem; 2008 Dec; 51(24):8135-47. PubMed ID: 19053749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery.
    Elmouelhi N; Aich U; Paruchuri VD; Meledeo MA; Campbell CT; Wang JJ; Srinivas R; Khanna HS; Yarema KJ
    J Med Chem; 2009 Apr; 52(8):2515-30. PubMed ID: 19326913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model.
    Rahman KM; Sarkar FH; Banerjee S; Wang Z; Liao DJ; Hong X; Sarkar NH
    Mol Cancer Ther; 2006 Nov; 5(11):2747-56. PubMed ID: 17121921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs.
    Aich U; Meledeo MA; Sampathkumar SG; Fu J; Jones MB; Weier CA; Chung SY; Tang BC; Yang M; Hanes J; Yarema KJ
    Glycoconj J; 2010 May; 27(4):445-59. PubMed ID: 20458533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxicity and MUC1 suppression.
    Aich U; Campbell CT; Elmouelhi N; Weier CA; Sampathkumar SG; Choi SS; Yarema KJ
    ACS Chem Biol; 2008 Apr; 3(4):230-40. PubMed ID: 18338853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9.
    Baek SH; Kim SM; Nam D; Lee JH; Ahn KS; Choi SH; Kim SH; Shim BS; Chang IM; Ahn KS
    Pharm Biol; 2012 Oct; 50(10):1210-8. PubMed ID: 22853317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic oligosaccharide engineering with N-Acyl functionalized ManNAc analogs: cytotoxicity, metabolic flux, and glycan-display considerations.
    Almaraz RT; Aich U; Khanna HS; Tan E; Bhattacharya R; Shah S; Yarema KJ
    Biotechnol Bioeng; 2012 Apr; 109(4):992-1006. PubMed ID: 22068462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embelin Inhibits Invasion and Migration of MDA-MB-231 Breast Cancer Cells by Suppression of CXC Chemokine Receptor 4, Matrix Metalloproteinases-9/2, and Epithelial-Mesenchymal Transition.
    Lee H; Ko JH; Baek SH; Nam D; Lee SG; Lee J; Yang WM; Um JY; Kim SH; Shim BS; Ahn KS
    Phytother Res; 2016 Jun; 30(6):1021-32. PubMed ID: 27030214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
    Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
    Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frondoside A has an anti-invasive effect by inhibiting TPA-induced MMP-9 activation via NF-κB and AP-1 signaling in human breast cancer cells.
    Park SY; Kim YH; Kim Y; Lee SJ
    Int J Oncol; 2012 Sep; 41(3):933-40. PubMed ID: 22710811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-metastatic effect of supercritical extracts from the Citrus hassaku pericarp via inhibition of C-X-C chemokine receptor type 4 (CXCR4) and matrix metalloproteinase-9 (MMP-9).
    Kim C; Kim D; Nam D; Chung WS; Ahn KS; Kim SH; Choi SH; Shim BS; Cho SK; Ahn KS
    Phytother Res; 2014 Sep; 28(9):1374-82. PubMed ID: 24638915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression.
    Ling H; Zhang Y; Ng KY; Chew EH
    Breast Cancer Res Treat; 2011 Apr; 126(3):609-20. PubMed ID: 20521099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery.
    Mathew MP; Tan E; Shah S; Bhattacharya R; Adam Meledeo M; Huang J; Espinoza FA; Yarema KJ
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6929-33. PubMed ID: 23041156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic monosaccharides altered cell responses to anticancer drugs.
    Chen L; Liang JF
    Eur J Pharm Biopharm; 2012 Jun; 81(2):339-45. PubMed ID: 22487054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line.
    Yodkeeree S; Ampasavate C; Sung B; Aggarwal BB; Limtrakul P
    Eur J Pharmacol; 2010 Feb; 627(1-3):8-15. PubMed ID: 19818349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MMP-2-mediated cellular invasion by NF-κB inhibitor DHMEQ in 3D culture of breast carcinoma MDA-MB-231 cells: A model for early phase of metastasis.
    Ukaji T; Lin Y; Okada S; Umezawa K
    Biochem Biophys Res Commun; 2017 Mar; 485(1):76-81. PubMed ID: 28188787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganoderic acids suppress growth and angiogenesis by modulating the NF-κB signaling pathway in breast cancer cells.
    Li F; Wang Y; Wang X; Li J; Cui H; Niu M
    Int J Clin Pharmacol Ther; 2012 Oct; 50(10):712-21. PubMed ID: 22762853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoalantolactone inhibits the migration and invasion of human breast cancer MDA-MB-231 cells via suppression of the p38 MAPK/NF-κB signaling pathway.
    Wang J; Cui L; Feng L; Zhang Z; Song J; Liu D; Jia X
    Oncol Rep; 2016 Sep; 36(3):1269-76. PubMed ID: 27461575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.